Cervical Adenocarcinoma in Situ

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-05-04
Clinical Trial Update: A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213) [Phase 3]
Phase 3 study evaluating the immunogenicity, safety and tolerability of the quadrivalent HPV vaccine V501 in Chinese girls aged 9-19 and you…